70 related articles for article (PubMed ID: 7428136)
1. Phase I-II clinical trial of gallium nitrate (NSC-15200).
Samson MK; Fraile RJ; Baker LH; O'Bryan R
Cancer Clin Trials; 1980; 3(2):131-6. PubMed ID: 7428136
[TBL] [Abstract][Full Text] [Related]
2. Gallium nitrate: the second metal with clinical activity.
Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
Cancer Treat Rep; 1986 Nov; 70(11):1311-9. PubMed ID: 3533251
[TBL] [Abstract][Full Text] [Related]
3. Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.
Crawford ED; Saiers JH; Baker LH; Costanzi JH; Bukowski RM
Urology; 1991 Oct; 38(4):355-7. PubMed ID: 1755146
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of gallium nitrate in patients with advanced malignant melanoma.
Casper ES; Stanton GF; Sordillo PP; Parente R; Michaelson RA; Vinceguerra V
Cancer Treat Rep; 1985 Sep; 69(9):1019-20. PubMed ID: 4028034
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD
Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.
Keller J; Bartolucci A; Carpenter JT; Feagler J
Cancer Treat Rep; 1986 Oct; 70(10):1221-3. PubMed ID: 3530448
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.
Warrell RP; Coonley CJ; Straus DJ; Young CW
Cancer; 1983 Jun; 51(11):1982-7. PubMed ID: 6839291
[TBL] [Abstract][Full Text] [Related]
8. Phase I clinical studies with gallium nitrate.
Bedikian AY; Valdivieso M; Bodey GP; Burgess MA; Benjamin RS; Hall S; Freireich EJ
Cancer Treat Rep; 1978 Oct; 62(10):1449-53. PubMed ID: 361223
[No Abstract] [Full Text] [Related]
9. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Baselga J; Kris MG; Scher HI; Phillips M; Heelan RT
Invest New Drugs; 1993 Feb; 11(1):85-6. PubMed ID: 8394297
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Adelson MD
Am J Clin Oncol; 1991 Aug; 14(4):349-51. PubMed ID: 1862766
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD; Hanjani P
Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II trial of gallium nitrate for advanced hypernephroma.
Schwartz S; Yagoda A
Anticancer Res; 1984; 4(4-5):317-8. PubMed ID: 6486736
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.
Canfield VA; Lyss AP
Invest New Drugs; 1993 Nov; 11(4):335-6. PubMed ID: 8157476
[No Abstract] [Full Text] [Related]
14. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Jabboury K; Frye D; Holmes FA; Fraschini G; Hortobagyi G
Invest New Drugs; 1989 Jul; 7(2-3):225-9. PubMed ID: 2793377
[TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
van Groeningen CJ; Leyva A; O'Brien AM; Gall HE; Pinedo HM
Cancer Res; 1986 Sep; 46(9):4831-6. PubMed ID: 2425959
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
Van Echo DA; Chiuten DF; Whitacre M; Aisner J; Lichtenfeld JL; Wiernik PH
Cancer Treat Rep; 1980; 64(12):1335-9. PubMed ID: 6781747
[TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
Supko JG; Balcerzak SP; Kraut EH
Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
[TBL] [Abstract][Full Text] [Related]
20. Phase I and preliminary phase II observations of high-dose intermittent 6-thioguanine.
Presant CA; Denes AE; Klein L; Garrett S; Metter GE
Cancer Treat Rep; 1980; 64(10-11):1109-13. PubMed ID: 7459896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
